Literature DB >> 29550297

Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.

Vladimir Reinharz1, Harel Dahari2, Danny Barash3.   

Abstract

Age-structured PDE models have been developed to study viral infection and treatment. However, they are notoriously difficult to solve. Here, we investigate the numerical solutions of an age-based multiscale model of hepatitis C virus (HCV) dynamics during antiviral therapy and compare them with an analytical approximation, namely its long-term approximation. First, starting from a simple yet flexible numerical solution that also considers an integral approximated over previous iterations, we show that the long-term approximation is an underestimate of the PDE model solution as expected since some infection events are being ignored. We then argue for the importance of having a numerical solution that takes into account previous iterations for the associated integral, making problematic the use of canned solvers. Second, we demonstrate that the governing differential equations are stiff and the stability of the numerical scheme should be considered. Third, we show that considerable gain in efficiency can be achieved by using adaptive stepsize methods over fixed stepsize methods for simulating realistic scenarios when solving multiscale models numerically. Finally, we compare between several numerical schemes for the solution of the equations and demonstrate the use of a numerical optimization scheme for the parameter estimation performed directly from the equations.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive stepsize integration; Age-structured model; Hepatitis C virus; Multiscale model; Numerical solution; Partial differential equations

Mesh:

Substances:

Year:  2018        PMID: 29550297      PMCID: PMC5992100          DOI: 10.1016/j.mbs.2018.03.011

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  36 in total

Review 1.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  Efficient and reliable schemes for nonlinear diffusion filtering.

Authors:  J Weickert; B H Romeny; M A Viergever
Journal:  IEEE Trans Image Process       Date:  1998       Impact factor: 10.856

3.  Rapid emergence of protease inhibitor resistance in hepatitis C virus.

Authors:  Libin Rong; Harel Dahari; Ruy M Ribeiro; Alan S Perelson
Journal:  Sci Transl Med       Date:  2010-05-05       Impact factor: 17.956

4.  Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.

Authors:  Harel Dahari; Jeremie Guedj; Alan S Perelson; Thomas J Layden
Journal:  Curr Hepat Rep       Date:  2011-07-02

5.  Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.

Authors:  J Guedj; A U Neumann
Journal:  J Theor Biol       Date:  2010-09-08       Impact factor: 2.691

6.  Modelling how ribavirin improves interferon response rates in hepatitis C virus infection.

Authors:  Narendra M Dixit; Jennifer E Layden-Almer; Thomas J Layden; Alan S Perelson
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

7.  Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents.

Authors:  Libin Rong; Alan S Perelson
Journal:  Math Biosci       Date:  2013-05-16       Impact factor: 2.144

8.  The role of cells refractory to productive infection in acute hepatitis B viral dynamics.

Authors:  Stanca M Ciupe; Ruy M Ribeiro; Patrick W Nelson; Geoffrey Dusheiko; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

9.  The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate.

Authors:  Jeremie Guedj; Harel Dahari; Susan L Uprichard; Alan S Perelson
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-07       Impact factor: 3.869

10.  Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model.

Authors:  Libin Rong; Jeremie Guedj; Harel Dahari; Daniel J Coffield; Micha Levi; Patrick Smith; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2013-03-14       Impact factor: 4.475

View more
  4 in total

1.  Machine learning for mathematical models of HCV kinetics during antiviral therapy.

Authors:  Alexander Churkin; Stephanie Kriss; Asher Uziel; Ashish Goyal; Rami Zakh; Scott J Cotler; Ohad Etzion; Amir Shlomai; Horacio G Rotstein; Harel Dahari; Danny Barash
Journal:  Math Biosci       Date:  2021-12-06       Impact factor: 2.144

2.  A Mathematical Model for early HBV and -HDV Kinetics during Anti-HDV Treatment.

Authors:  Rami Zakh; Alexander Churkin; William Bietsch; Menachem Lachiany; Scott J Cotler; Alexander Ploss; Harel Dahari; Danny Barash
Journal:  Mathematics (Basel)       Date:  2021-12-20

3.  Advances in Parameter Estimation and Learning from Data for Mathematical Models of Hepatitis C Viral Kinetics.

Authors:  Vladimir Reinharz; Alexander Churkin; Harel Dahari; Danny Barash
Journal:  Mathematics (Basel)       Date:  2022-06-19

4.  Control strategy design for the anti-HBV mathematical model.

Authors:  Yi Ding; Wen-June Wang
Journal:  IET Syst Biol       Date:  2019-08       Impact factor: 1.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.